Design of novel F-ATP synthase inhibitors of mycobacterium tuberculosis
F1FO ATP synthase of Mycobacterium tuberculosis is an attractive and intensively-studied drug target. Adenosine triphosphate (ATP) is necessary for cell growth and is vital for cell survival, especially in the case of dormant Mycobacterium. In 2012, an inhibitor of F1FO ATP synthase, Bedaquiline (BD...
Saved in:
主要作者: | |
---|---|
其他作者: | |
格式: | Theses and Dissertations |
語言: | English |
出版: |
2018
|
主題: | |
在線閱讀: | http://hdl.handle.net/10356/75829 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
機構: | Nanyang Technological University |
語言: | English |